BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23087643)

  • 1. Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.
    Moran VE
    Front Pharmacol; 2012; 3():173. PubMed ID: 23087643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cotinine enhances the extinction of contextual fear memory and reduces anxiety after fear conditioning.
    Zeitlin R; Patel S; Solomon R; Tran J; Weeber EJ; Echeverria V
    Behav Brain Res; 2012 Mar; 228(2):284-93. PubMed ID: 22137886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine-Derived Compounds as Therapeutic Tools Against Post-Traumatic Stress Disorder.
    Barreto GE; Yarkov A; Avila-Rodriguez M; Aliev G; Echeverria V
    Curr Pharm Des; 2015; 21(25):3589-95. PubMed ID: 26166610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?
    Echeverria V; Grizzell JA; Barreto GE
    Curr Pharm Des; 2016; 22(10):1324-33. PubMed ID: 26972290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.
    Grizzell JA; Echeverria V
    Neurochem Res; 2015 Oct; 40(10):2032-46. PubMed ID: 24970109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
    BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotinine reduces depressive-like behavior, working memory deficits, and synaptic loss associated with chronic stress in mice.
    Grizzell JA; Iarkov A; Holmes R; Mori T; Echeverria V
    Behav Brain Res; 2014 Jul; 268():55-65. PubMed ID: 24713149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parents' Self-efficacy for Tobacco Exposure Protection and Smoking Abstinence Mediate Treatment Effects on Child Cotinine at 12-Month Follow-up: Mediation Results from the Kids Safe and Smokefree Trial.
    Collins BN; Lepore SJ; Winickoff JP; Sosnowski DW
    Nicotine Tob Res; 2020 Oct; 22(11):1981-1988. PubMed ID: 31536116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions.
    Tan X; Vrana K; Ding ZM
    Front Behav Neurosci; 2021; 15():758252. PubMed ID: 34744656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cotinine: a potential new therapeutic agent against Alzheimer's disease.
    Echeverria V; Zeitlin R
    CNS Neurosci Ther; 2012 Jul; 18(7):517-23. PubMed ID: 22530628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy.
    George L; Granath F; Johansson AL; Cnattingius S
    Acta Obstet Gynecol Scand; 2006; 85(11):1331-7. PubMed ID: 17091413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of cotinine in the cognitive and neuroprotective actions of nicotine.
    Buccafusco JJ; Terry AV
    Life Sci; 2003 May; 72(26):2931-42. PubMed ID: 12706481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of nicotine and cotinine in meconium from Greek neonates and correlation with birth weight and gestational age at birth.
    Tsinisizeli N; Sotiroudis G; Xenakis A; Lykeridou KE
    Chemosphere; 2015 Jan; 119():1200-1207. PubMed ID: 25460762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex/Gender Differences in Cotinine Levels Among Daily Smokers in the Pennsylvania Adult Smoking Study.
    Chen A; Krebs NM; Zhu J; Sun D; Stennett A; Muscat JE
    J Womens Health (Larchmt); 2017 Nov; 26(11):1222-1230. PubMed ID: 28872928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No increased levels of the nicotine metabolite cotinine in smokers with schizophrenia.
    Bozikas VP; Niopas I; Kafantari A; Kanaze FI; Gabrieli C; Melissidis P; Gamvrula K; Fokas K; Karavatos A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):1-6. PubMed ID: 15610938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time.
    Sastry BV; Chance MB; Singh G; Horn JL; Janson VE
    Pharmacology; 1995 Feb; 50(2):128-36. PubMed ID: 7716176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine and cotinine in adults' urine: The German Environmental Survey 1998.
    Heinrich J; Hölscher B; Seiwert M; Carty CL; Merkel G; Schulz C
    J Expo Anal Environ Epidemiol; 2005 Jan; 15(1):74-80. PubMed ID: 15150534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotinine effects on nicotine metabolism.
    Zevin S; Jacob P; Benowitz N
    Clin Pharmacol Ther; 1997 Jun; 61(6):649-54. PubMed ID: 9209247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biomarkers of tobacco smoke exposure].
    Berny C; Boyer JC; Capolaghi B; De L'Homme G; Desch G; Garelik D; Hayder R; Houdret N; Jacob N; Koskas T; Lainé G; Le Moel G; Moulsma M; Plantin-Carrenard E; Venembre P
    Ann Biol Clin (Paris); 2002; 60(3):263-72. PubMed ID: 12050041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition.
    Terry AV; Hernandez CM; Hohnadel EJ; Bouchard KP; Buccafusco JJ
    CNS Drug Rev; 2005; 11(3):229-52. PubMed ID: 16389292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.